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                  Thank  you  indeed  to  Christopher  Plowe  for  the  very  gener-
ous introduction—I think it was perhaps too generous. Chris 
showed the list of fellows and students who have worked with 
me at National Institutes of Health (NIH), and great credit 
really goes to them. I have been fortunate and privileged to 
have been surrounded by the brilliance of all of these individ-
uals and their accomplishments through the years. Also, Chris 
did not name himself in the photographs with our Malian col-
leagues, instead referring to himself only as one of the “less 
talented” fellows. Not at all! In fact, Chris was overly generous 
to me when he spoke of our field work in Mali on chloroquine 
resistance. It really was Chris’ project with Abdoulaye Djimdé 
while I was collaborating on much of that work. So I return 
the credit for that to Chris, with the comment that it was par-
ticularly rewarding to see the impact on health in the villages 
where we collaborated with our Malian colleagues to deliver 
relatively inexpensive medicines that worked wonders. 
  Tonight marks the end of a wonderful experience for me 
as your   ASTMH   President. The period has left me with last-
ing memories, new colleagues, and friends. And it is a great 
satisfaction to say that this extraordinary Society continues 
to grow in strength and collective voice as the leading inter-
national organization of scientists and clinicians dedicated to 
tropical medicine and global health.   ASTMH   is alive with an 
abundance of positive spirit and teamwork in our membership. 
This year we have held our largest and most successful Annual 
Meeting ever, with over 3,400 registrants. We have also seen 
excellent progress in areas of membership, policy and advo-
cacy, media communications, and awards program funding. 
Time does not allow me to thank by name everyone who made 
this progress possible. However, I would like to express my 
gratitude to some individuals in particular: 
    To Sally Finney, our Executive Director, for her initia- ￿ 
tive and careful attention to our   ASTMH   activities this 
year. These have included the Policy and Advocacy work 
with Kent Campbell, the upcoming   ASTMH   Constitution 
and Bylaws revisions, the launch of our Public Relations 
Committee, the media relations contract with the MWW 
Group, and the coordination of our Executive Committee 
and Council meetings;   
    To Judy DeAcetis, Lyn Maddox, Matthew Lesh, and their  ￿ 
Sherwood Group Colleagues for their attentive care to this 
year’s operations including the meeting arrangements, the 
drive to boost membership, and the wide-ranging adminis-
trative needs of our Society.   
    To Chris King and the approximately 100 members of our  ￿ 
Scientific Program Committee for their contributions of 
time, thought, and effort putting together a terrific Meeting 
Agenda this year.   
    To the members of the   ￿  ASTMH   Council, especially Josh 
Berman, Peter Weller, Jim Kazura, Ed Ryan, Claire Panosian, 
Joe Vinetz, Steve Higgs, plus so many other Society mem-
bers I have not named—thank you all for your generous ser-
vice to   ASTMH   this year.   
    Finally, to my wife Marilyn, daughter Dianne, and sons Alex  ￿ 
and Nick and their wives Lauren and Alysen: your love and 
unaffected eloquence in our family have meant everything 
to me over the years; and thank you very much for your sup-
port through a busy and eventful 2009.             
  Formative  influences.     The call to give this Society’s 
presidential address presents an opportunity to choose among 
almost limitless topics across subjects of tropical public health, 
scientific discovery, our history, and aspects of policy and 
advocacy tied to the goals of   ASTMH  . As an attendee of these 
addresses in previous years, I have enjoyed hearing previous 
presidents talk of their career experiences in the context of 
their   ASTMH   interests, particularly when these have touched 
on major events that have molded and restructured our 
perspective and activities in today’s world. My thoughts in 
this regard returned me to some memories from my graduate 
student experiences at the University of Chicago. These were 
under two of my PhD advisors in structural biology, Robert 
Josephs and Paul B. Sigler. My thesis work in those years was 
on the fibers and crystals of deoxygenated hemoglobin that 
can form in erythrocytes when there is a mutation from valine 
to glutamate in the sixth position of the hemoglobin beta 
chain, namely, the sickle-cell mutation.  1,  2   Those  experiences 
were among the stimuli that eventually brought me to malaria 
research, a personal path that I will not go into tonight. Instead, 
I would like to use this address to touch upon some of the 
profound influences of the scientist who more than any other 
established the field of my PhD research. He determined 
the structure of hemoglobin, investigated the effects of its 
mutations, and established core legacies of molecular medicine 
and molecular biology at the Cavendish Laboratory and 
Cambridge University in England. 
   A    long-term  quest  of  fundamental  discovery.    Max  Perutz 
decided to pursue the structure of hemoglobin in 1937, at 
a time when genes were generally thought to be proteins, 
and when proteins acting as enzymes had only recently 
been recognized to catalyze chemical reactions in living 
systems. Perutz saw protein structure as a central problem of 
biology, and he recognized that the only way to approach it 
was by x-ray crystallography.  3   He also saw hemoglobin as a 
molecule of immense importance and mystery, especially in 
the mechanisms by which it transported oxygen and carbon 
dioxide in the bloodstream. The existence of regular crystals 
of hemoglobin suggested to Perutz that the molecule’s 
enormous number of atoms could take a specific shape and 
that the resulting structure would hold the key to how the 
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molecule worked. However, in 1937, no one knew how to go 
about solving the structure of such a protein; indeed, there was 
widespread belief that the prospects for success were bleak 
and the goal was scarcely realistic, if not unattainable.  4,  5  Perutz, 
under generous support and advice from William Lawrence 
Bragg and John Desmond Bernal,  6   nevertheless pursued the 
structure. 
  My first exposure to the optimism and persistence with 
which Max Perutz took on the hemoglobin problem was in 
my reading of a paper he contributed in 1948 in honor of the 
British physiologist Sir Joseph Barcroft. At that point his goal 
must have seemed distant indeed, for he wrote:
    “On the face of it … an attempt to analyze the crystal 
structure of hemoglobin, or of any crystalline protein for 
that matter, looks about as promising as a journey to the 
moon.”  7    
  This at a time when space travel was still a story of science 
fiction and the dream of reaching the moon was only the stuff 
of a love song. It was a marvel, I thought, to read Perutz’s 
assessment of the hemoglobin structure problem as a possibly 
forlorn undertaking. He had no clear route yet to the protein 
structure—in fact, his model at that time would prove wrong—
but he concluded in his paper that there remained “a variety 
of different ways of approach to the problem of protein struc-
ture. Some of these ways have proved dead ends, but many are 
still leading on.”  7   His decades of single-minded pursuit of a 
distant goal of major importance, by paths not at all clear, not 
even sure to be possible, struck me as a tremendous model for 
a career in scientific discovery. 
  Perutz received critical support for his work during this 
period from the Medical Research Council and its Secretary 
Sir Edward Mellanby. In 1947, Bragg met with Mellanby and 
explained the difficulty of the work, the remote chances of suc-
cess and, if success were achieved, the likelihood that it might 
well be a long time before the information would be of practi-
cal use to medicine. Mellanby accepted the risk, and he decided 
to support the research.  4   After Mellanby retired in 1949, Sir 
Harold Himsworth became Secretary of the MRC and con-
tinued strong support for the work. Eventually, Perutz wrote 
a book in 1992 entitled   Protein Structure: New Approaches to 
Disease and Therapy  , and he dedicated it to Himsworth, writ-
ing that “[Himsworth’s] foresight and courage led him to sup-
port my colleagues and my early work on protein structures 
when there was only the faintest hope of it ever benefitting 
medicine.”  8  
  By 1970, a year after the Apollo 11 moon landing, Perutz’s 
determination was not only vindicated by his solution of the 
structure of hemoglobin (  Figure 1  )—he had also developed 
an essential description of the cooperative operations by 
which it functions as a breathing molecule.  9   The exchange of 
gases and the physiological phenomenon of the Bohr effect 
were explained at the level of individual atoms, and he and 
Hermann Lehmann had linked clinical manifestations of a 
variety of genetic mutations to the positions and influence of 
individual amino acid substitutions.  10  
    The breakthroughs of Perutz and his colleagues in crystal-
lography not only revealed the hemoglobin molecule in all 
its wonder and, as he put it, its “simple beauty”  5 —the  break-
throughs also set the stage for the elucidation of a world of 
structures from biological systems. More than 50,000 protein 
structures are now available over the internet from the RCSB 
Protein Data Bank,  11   and applications have reached into vital 
areas of medicine including, for example, the development of 
drugs against influenza, protease inhibitors against HIV-1/
AIDS, and captopril for the treatment of hypertension and 
heart failure.  12  
  Yet Perutz’s legacy extends even more broadly. As group 
head of the Cavendish Laboratory Unit under Medical 
Research Council (MRC) support, and subsequently as 
Chairman of the Cambridge MRC Laboratory of Molecular 
Biology, Perutz recruited and supported an astonishing num-
ber of brilliant colleagues. 
 It is still fascinating to recall the names and accomplishments 
from the Cavendish Unit and the Cambridge Laboratory: 
Watson and Crick and the DNA double helix; John Kendrew 
and the structure of myoglobin; Sydney Brenner and the 
  Caenorhabditis elegans   animal development model; Vernon 
Ingram and identification of the β6 hemoglobin substitution 
responsible for sickle-cell anemia; Hugh Huxley and the slid-
ing filament model for muscle contraction; Cesar Milstein and 
the hybridoma technique for monoclonal antibody produc-
tion; Aaron Klug and the structural determination of nucleic 
acid-protein complexes; and Frederick Sanger and sequencing 
methods that elucidated the first full DNA sequence of a viral 
genome (Phage Φ-X174).  6,  13  
  Perutz’s belief in enlisting ambitious and creative scientists 
and giving them what they needed to succeed was an essential 
character of his chairmanship years. He recognized scientific 
creativity, he recognized what could kill it, and he understood 
the value of an environment in which young scientists were 
given the intellectual freedom to pursue their ideas—of an 
environment in which they were not told what to do, but they 
had to find out what to do by themselves.  4,  5  
      Science and applications of science.     Perutz was deeply 
committed to the importance of scientific thinking and the 
value of basic research for a foundation of human betterment 
and human purposes. He used his voice as a Nobel Laureate 
to advocate for human rights and promote his conviction that 
 Figure  1.       Depiction of the crystal structure of human deoxyhe-
moglobin at 1.74 Å resolution. The Protein Data Bank Data (ID: 
2HHB) of Fermi and others  33   were downloaded and displayed using 
the RCSB Protein Workshop Viewer (  http://www.rcsb.org/pdb/  ). This 
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“scientists the world over are united by a common purpose, 
ideally to discover Nature’s secrets and put them to use for 
human benefit”.  14  
  It was also in Perutz’s nature to value research done for its 
own sake, in his words: to “discover the strange workings of a 
wonderful world.”  6  
  Many of you will probably recognize the book written in 
1997 by Donald Stokes,   Pasteur’s Quadrant: Basic Science and 
Technological Innovation . 15   This book was also mentioned 
by Carlos Morel in his Commemorative Fund Lecture at last 
year’s   ASTMH   Annual Meeting in New Orleans.  16   Stokes’ 
history provides an absorbing treatment of the distinctions 
that are frequently drawn between classifications of basic 
and applied research, and of how these distinctions have been 
incorporated into various institutional policies and govern-
ment funding, particularly in the years since Vannevar Bush’s 
1945 report   Science—the Endless Frontier . 17   Stokes’ thesis is 
that classifications of research in a one-dimensional model 
from basic to applied often fail to recognize the full range and 
motivation of investigations in science. He offers a diagram 
of two-dimensions in which research falls into cells or quad-
rants, depending upon the degree to which scientific efforts 
are motivated by the goals of 1) fundamental understanding 
and 2) considerations of use. 
  In Stokes’ diagram (  Figure 2  ), the lower right quadrant 
includes the work of the inventor Thomas Edison, who was 
famous for his quests for applications alone, without inter-
est to develop fundamental scientific theories. The physics 
of Niels Bohr is placed in the upper left quadrant because of 
his passion for fundamental understanding on the basic level. 
And, in the upper right quadrant, are bodies of scientific work 
motivated both by curiosity about fundamental principles of 
nature and by the search for useful applications. Stokes named 
this quadrant after Louis Pasteur, who strove to understand 
the processes of disease at the most fundamental level, while 
at the same time he worked to develop ways to deal with major 
problems including anthrax, milk and wine spoilage, chicken 
cholera, rabies, and silk worm infections. 
    But I wonder how clearly motivations based on “consider-
ations of use” distinguish the quadrants of Pasteur and Bohr. 
Pasteur once famously remarked “Il n’existe pas de sciences 
appliquées, mais seulement des applications de la science. 
[There are no such things as applied sciences, only applica-
tions of science],”  18   also, that science and its applications are 
“liées entre elles comme le fruit à l’arbre qui l’a porté [linked 
together as fruit is to the tree that has borne it].”  19  
  With these words in mind, consider Niels Bohr. He was a 
profound scientist, a preeminent creator of fundamental phys-
ics and a philosopher of natural phenomena, but he was like-
wise an orchestrator of experimental science, a builder of a 
renowned research Institute in Copenhagen, a helper of ref-
ugees, and a passionate advocate for international openness 
in the spirit of glastnost.  20   The son of Danish physiologist 
Christian Bohr, for whom the Bohr hemoglobin effect studied 
by Max Perutz is named, Niels Bohr also looked for ways to 
bring physics into biology and medicine. This he did astonish-
ingly well following a 1933 decision by Warren Weaver and the 
Rockefeller Foundation to focus on support for experimental 
biology as its primary field of interest in the natural sciences. 
With funding from the Rockefeller Foundation, Bohr sup-
ported his friend and colleague George de Hevesy, who pur-
sued work with inducible radioactive tracers in Copenhagen 
after these were first produced by Marie Curie’s daughter 
Irène and her husband Frédéric Joliot.  20   Hevesy’s work with 
artificial tracers spurred revolutionary applications in biology 
and founded the field of nuclear medicine.  20,  21  
  Bohr’s enthusiasm for bringing physics to biology had a 
notable influence in another direction as well. This was an 
influence I first learned about in 1984, shortly after I joined 
NIH’s malaria research group under Louis Miller, in the 
Laboratory of Parasitic Diseases directed by Franklin Neva. 
It was an exciting time: DNA sequences of the   Plasmodium 
falciparum   circumsporozoite protein (CSP) identified by Ruth 
Nussenzweig were being published,  22,  23   and I began a project 
with Russell Howard to clone and characterize the sequence 
of a malaria parasite gene we termed   pfhrp2 . 24   Sequence 
information from the CSP gene is used today in the RTS,S 
recombinant malaria vaccines; and the sequences of PfHRP2 
serve as the basis for a number of the rapid diagnostic tests 
that are now widely deployed for the detection of   P. falci-
parum   infection. In 1984, lambda bacteriophages, plasmids, 
and selected   Escherichia coli   strains were the working clon-
ing systems in these projects. For methods and information we 
routinely turned to publications from the Cold Spring Harbor 
Laboratory, mainly   Molecular Cloning: A Laboratory Manual  
published in 1982 by Tom Maniatis, Joe Sambrook, and Edward 
Fritsch.  25  
  So, what was the influence that connects Niels Bohr, molec-
ular biology at Cold Spring Harbor, and the cloning methods 
for the genes I mentioned? In a 1932 address entitled “Light 
and Life,” Bohr reflected on the principles of complementar-
ity in physics and asked whether analogous principles might 
be needed to understand living organisms.  26,  27   Max Delbrück, 
an associate of Bohr’s in theoretical physics, was so taken with 
 Figure  2.       Quadrant model of research motivations proposed by 
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the address that he decided to change the course of his career 
from physics to biology.  28,  29  
  Delbrück turned to biology with the view that a detailed 
examination of living systems might uncover paradoxical phe-
nomena similar to those that had confronted physicists in 
quantum physics. He did not succeed to find such phenom-
ena, eventually coming to the view that all dynamic systems 
of biology are reducible and follow the laws of physics and 
chemistry.  30   But his search proved extraordinarily fruitful, as 
his ideas spurred fundamental investigations into the physical 
properties of the gene, and he and Salvador Luria opened up 
a new world of molecular genetics in their demonstrations of 
evolution by random mutation. Along with Luria, Delbrück 
initiated the famous phage group at the Cold Spring Harbor 
Laboratory (  www.cshl.edu/history/Delbrück.html  ), in the 
same spirit of scientific associations that were present in the 
Copenhagen group around Bohr.  3  
   Past  is  prologue.     A half century after the molecular and 
genetic breakthroughs of Perutz and Delbrück, we have 
before us today entire genome sequences of pathogens and 
hosts, and we also have the understanding and wherewithal to 
manipulate the components of these living systems as never 
before.  The advances we are witnessing in biology and medicine 
are just some of the benefits of the physical and social sciences 
to the human condition, as they join with advances across 
areas of nutrition, water and sanitation, telecommunications, 
agriculture, energy production, and transportation, with 
remarkable potential to improve health and well-being. 
  In many countries of the world, the effects of these benefits 
are evident in two measures of health and well-being: life expec-
tancy at birth and income per person. Some of you are proba-
bly familiar with the trends analysis of these measures by Hans 
Rosling, Professor of International Health at the Karolinska 
Institutet and Director of the Gapminder Organization. His 
presentations bring global health and economic trends to life. 
  Figure 3   shows a Gapminder series comparing life expectancy 
at birth and income per person from 1827, a year roughly 
between the time Edward Jenner began using the cowpox vac-
cine against smallpox and the time John Snow removed the 
Broad Street pump handle in his great epidemiological advance 
against cholera. From a life expectancy range of 25 to 40 years 
in the early 1800s, this expectancy has increased for most coun-
tries, increasing first in the industrialized countries, for exam-
ple in Europe and North America. And life expectancy then 
shows great improvements in some other large populations, 
for example in India and China, where about 50 years ago life 
expectancy began increasing at a rate almost twice as fast as 
the earlier rates in Europe and North America. For India and 
China the increases in life expectancy began some years before 
the increases in prosperity. As Rosling points out for these sta-
tistics, “you get wealthy faster if you’re healthy first.” 
    There is momentum in these gains, and it is in the right 
direction. We know that in many countries of Africa and some 
other regions of the world, overall improvements have lagged. 
But past is prologue, and the momentum of the gains tells us 
we can be confident that better conditions of health will be fol-
lowed by increases in prosperity. 
  I am proud to say it is on these challenges of health that our 
  ASTMH   membership focuses:
      We work as a worldwide organization to prevent and con- ￿ 
trol infectious and other diseases that disproportionately 
afflict the global poor.   
    Our goals include advancing research on tropical diseases,  ￿ 
fostering international scientific collaborations, promoting 
science-based policy, and supporting education and career 
 Figure  3.       Gapminder comparisons of life expectancy at birth vs. income per person in 1827, 1887, 1947, and 2007. Colored circles represent 
countries from different regions of the world, and the size of each bubble represents a country’s population. Plots were generated from data and 
software at the Gapminder web site:   http://www.gapminder.org/.   This figure appears in color at   www.ajtmh.org  .       5 PRESIDENTIAL ADDRESS
development of professionals in tropical medicine and 
global  health.    
  President Obama this year pointed out that “Science is 
more essential for our prosperity, our security, our health, 
our environment, and our quality of life than it has ever been 
before” and “… many of the challenges that science and tech-
nology will help us meet are global in character.”  31   Science is 
at the heart of our goals in   ASTMH  , and the innovations that 
follow from investments in science, from fundamental discov-
eries and their applications, will give us vital means to meet 
these goals. 
  A report recently announced by the National Research 
Council’s Board on Life Sciences, “  A New Biology for the 21st 
Century, ” 32   opens by asking that we imagine a world where:
      there is abundant, healthful food for everyone    ￿ 
    the environment is resilient and flourishing    ￿ 
    there is sustainable, clean energy    ￿ 
  good  health  is  the  norm     ￿ 
  In calling for a national initiative to address these goals, the 
report reaffirms the role of fundamental research endeavors 
and recommends that they be met by integrated, interdisci-
plinary efforts across the biological and physical sciences. 
These recommendations echo the approaches of Perutz, Bohr, 
and their colleagues as they brought concepts of physical sci-
ences and new computational technology to great advances in 
biology a half century ago. Scientific discovery and its appli-
cations give us the platform for continued progress that will 
improve our collective ability to control disease, improve eco-
nomic production, and nourish and support our world’s pop-
ulations. Even in the face of issues of climate change, global 
population burden, environmental depredations, and emerg-
ing disease threats, science and its processes give us capacities 
scarcely imaginable just a few decades ago; and future capaci-
ties will come that we can scarcely imagine today. 
  The ways of thinking that have enabled us to travel to the 
moon, and have given us new ways to understand ourselves and 
the universe, have the power to meet these goals. But we must 
stay energetic in our endeavors to discover and learn. Max 
Perutz once said of his optimism and persistence in the face of 
seemingly intractable difficulties toward his goal: “As always, 
I was driven on by unrealistic expectations.”  3   He harnessed 
new knowledge, information, and technological capacities to 
meet those expectations. If there seem to be any advances in 
global health or in prosperity that seem likewise unrealistic, 
I would counter that momentum of the gains is with us, and 
new discoveries and their applications continue to give us tre-
mendous potential. 
  Our endeavors toward these discoveries and applications 
will forever remain worthy of our most ambitious dreams. 
    Received January 19, 2010. Accepted for publication February 22, 
2010.    
    Disclosure: Presented as the Presidential Address at the 58th Annual 
Meeting of the American Society of Tropical Medicine and Hygiene, 
Washington, DC, November 21, 2009.   
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